By Yantoultra Ngui

SINGAPORE (Reuters) -The owners of aland Health Holding, a China-based global nutritional supplement maker, are seeking to sell their combined controlling stake, targeting a valuation of more than $1.5 billion, two sources with knowledge of the matter said.

Founder and chairman Chang Liang holds around 60% of the company, with the remaining shares held by investment firms including Affinity Equity Partners, Goldman Sachs Growth Equity and Henderson Investment Corp, the sources said.

The company, which is on track to generate about $150 million in annual earnings before interest, taxes, depreciation and amortisation (EBITDA) this year, has attracted preliminary interest from strategic buyers and private equity firms, one of the sources said.

Aland’s U.S. footprint, dr

See Full Page